Related Experiment Video
Updated: Jul 2, 2026
05:56
Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
UVA/riboflavin-induced apoptosis in mouse cornea
1Department of Ophthalmology, University Hospital Carl Gustav Carus, Dresden University of Technology, Dresden, Germany. fanwang_hh@yahoo.com
Summary
Ultraviolet A (UVA)/riboflavin treatment in vitro created a cell-free corneal stroma in mice. This method may reduce graft rejection and improve corneal transplant survival.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Immunology
Background:
- A novel mouse model utilizes combined ultraviolet A (UVA) and riboflavin irradiation.
- This technique aims to eliminate corneal stromal cells and antigen-presenting cells.
- The goal is to reduce the risk of rejection in corneal transplantation.
Purpose of the Study:
- To investigate the efficacy of UVA/riboflavin irradiation in creating a cell-free corneal stroma.
- To assess the potential of this method in preventing immunological reactions and graft rejection.
- To evaluate the impact on corneal graft survival.
Main Methods:
- Mouse corneas underwent epithelial abrasion followed by in vitro UVA/riboflavin treatment.
- Histological analyses included hematoxylin-eosin and caspase 3 immunohistochemical staining.
- Western blot analysis was performed on dissected mouse corneas.
Main Results:
- UVA/riboflavin irradiation induced apoptosis in central corneal stromal cells, creating a cell-free zone.
- The number of dead cells increased with cultivation time.
- Corneal endothelium survival was maintained by adjusting the irradiation dose.
Conclusions:
- In vitro UVA/riboflavin irradiation successfully generated a cell-free stromal zone in mouse corneas.
- Pretreatment of donor corneas with this technique can prevent or reduce immunological reactions.
- This approach holds promise for prolonging corneal graft survival by minimizing rejection.
